Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04362592 · ClinicalTrials.gov registry record · NA
In-Utero Endoscopic Correction of Spina Bifida
A NA study of Spina Bifida and Myelomeningocele, sponsored by University of Southern California.
- Recruiting
- Registry status
- NA
- Development phase
- 110
- Enrollment target
- 2
- Study locations
NCT04362592: Recruiting NA study of Spina Bifida and Myelomeningocele, sponsored by University of Southern California.
NCT04362592 is a NA study of Spina Bifida and Myelomeningocele that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 110 participants, above the 46-participant average among 16 other Spina Bifida trials with a reported enrollment target (139% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04362592, a NA study of Spina Bifida and Myelomeningocele, is actively recruiting participants, sponsored by University of Southern California.
- RECRUITING
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to evaluate the feasibility and effectiveness of performing fetoscopic surgical correction of fetal spina bifida. Two surgical approaches will be utilized: the percutaneous technique versus the laparotomy/uterine exteriorization technique.
Primary Outcome
Successful fetoscopic closure of the defect
Conditions Studied
Interventions
- DEVICE In Utero Endoscopic Correction of Myelomeningocele IDE - Percutaneous Technique
- DEVICE In Utero Endoscopic Correction of Myelomeningocele IDE - Laparotomy/Uterine Exteriorization Technique
Study Locations (2)
California
- Hollywood Presbyterian Medical Center - Los Angeles
Florida
- Wellington Regional Medical Center - Wellington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2018-11-02 |
| Est. Completion | 2031-10-31 |
| Phase | NA |
What NCT04362592 shows while recruiting
NCT04362592 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, above the 46-participant average among 16 other Spina Bifida trials with a reported enrollment target (139% higher).
The record links to 3 conditions, with Spina Bifida appearing as the primary indexed condition, and to 2 interventions - of which In Utero Endoscopic Correction of Myelomeningocele IDE - Percutaneous Technique is the first listed.
NCT04362592 reports a single indexed study location in California, Florida.
Frequently Asked Questions
What is clinical trial NCT04362592 about?
NCT04362592 is a clinical study titled "In-Utero Endoscopic Correction of Spina Bifida". The purpose of this study is to evaluate the feasibility and effectiveness of performing fetoscopic surgical correction of fetal spina bifida. Two surgical approaches will be utilized: the percutaneous technique versus the laparotomy/uterine exteriorization technique.
What is the current status of trial NCT04362592?
This trial is currently recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2018-11-02. Estimated completion is 2031-10-31.
What conditions does trial NCT04362592 study?
This clinical trial studies the following conditions: Spina Bifida, Myelomeningocele, Neural Tube Defects.
What interventions are being tested in trial NCT04362592?
The interventions under investigation include: In Utero Endoscopic Correction of Myelomeningocele IDE - Percutaneous Technique (DEVICE), In Utero Endoscopic Correction of Myelomeningocele IDE - Laparotomy/Uterine Exteriorization Technique (DEVICE).
Who is sponsoring clinical trial NCT04362592?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04362592 being conducted?
This trial has 2 study locations across California, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spina Bifida
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04362592's enrollment target sits among peer trials
110 3rd of 16 higher than 14 of 16 other Spina Bifida trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spina Bifida trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
RECRUITING · NA
-
Transcutaneous Tibial Nerve Stimulation (TTNS) Treatment in Spina Bifida Pediatric Patients With Neurogenic Bladder
RECRUITING · NA
-
Laparotomy Versus Percutaneous Endoscopic Correction of Myelomeningocele
RECRUITING · NA
-
Autologous Human Umbilical Cord Tissue Patch for Postnatal Closure of Open Neural Tube Defects
RECRUITING · NA
-
Transcutaneous Spinal Stimulation for Children and Youth With Spina Bifida
RECRUITING · NA
-
Mobile Health Self-Management and Support System for Chronic and Complex Health Conditions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI